Avita Medical | 1811094D - Interest Expense On Debt


Avita Medical reported AUD1.25M in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Accuray USD 2.88M 72K Dec/2024
Celltrion KRW 19B 1.96B Jun/2025
Clinuvel Pharmaceuticals AUD 2.49M 51.97K Jun/2025
Cochlear AUD 6.3M 3.65M Dec/2025
CSL USD 215M 111M Dec/2025
Cspc Pharmaceutical CNY 6.76M 3.43M Dec/2025
Deva Holding AS TRY 272.53M 69.04M Sep/2023
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 60M 0 Jun/2026
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Mayne Pharma AUD 1.2M 50K Jun/2024
Medical Developments International AUD 18K 3K Jun/2025
Nanosonics AUD 779K 94K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Organigram Holdings CAD 179K 127K Mar/2025
Ovoca Bio EUR 7K 6K Jun/2022
Pharma Mar EUR 117K 1.24M Sep/2025
Polynovo AUD 506K 130K Jun/2025
PYC Therapeutics AUD 17K 11K Jun/2025
Qiagen NV USD 10.02M 1.03M Jun/2026
Ramsay Health Care AUD 300.6M 15.5M Dec/2025
ResMed USD 775K 886K Dec/2024
Sartorius EUR 44.9M 4.6M Sep/2026
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Telix Pharmaceuticals AUD 19.39M 11.77M Jun/2026
Tilray USD 6.7M 2.73M Jun/2025
Zealand Pharma A/S 7.07M 74K Dec/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025